Lumify®

Brimonidine Tartrate 0.025%
ophthalmic solution
Aesthetics/Presbyopia
[ Adrenergic Receptor Agonist (primarily alpha-2)]
Indication

Indication

OTC eye whitener
Mechanism of Action

Mechanism of Action

Selectively constricts venules, reducing ocular redness
Common quantities available

Available Quantities

2.5 ml, 7.5 ml
Dosage

Dosage/Instructions

Instill 1 drop in the affected eye(s) every 6-8 hours
Pregnancy & Nursing Data

Pregnancy & Nursing

No teratogenicity in rats at 360 times the normal human dosage. Use with caution during pregnancy and nursing. No adequate and well-controlled studies in pregnant women.
Pediatric Use

Pediatric Use

≥5 years
Warnings Tab

Contraindications, side effects, etc.

Contraindications: Not recommended if allergic to brimonidine. Caution advised for those with heart problems, circulation issues, coronary artery disease, low blood pressure, depression, Raynaud’s syndrome, or Buerger disease. Warnings: Should not be used more than four times daily. Avoid if the liquid is cloudy or has particles. Side Effects: Common side effects include mild itching, redness, burning, or other eye irritation, dry mouth, and drowsiness. Severe effects include eye pain, increased watering, vision changes, and severe swelling, redness, burning, or discomfort around the eye​​​​​​.